Experimental and real-world evidence supporting the computational repurposing of bumetanide for APOE4-related Alzheimer's disease
{{output}}
The evident genetic, pathological, and clinical heterogeneity of Alzheimer's disease (AD) poses challenges for traditional drug development. We conducted a computational drug repurposing screen for drugs to treat apolipoprotein (apo) E4-related AD. We first es... ...
